Loading provider…
Loading provider…
Hematology & Oncology Physician in Bronx, NY
NPI: 1013933290Primary Practice Location
MONTEFIORE MEDICAL CENTER
3415 Bainbridge Ave, Bronx, NY
Primary Employer
Montefiore Medical Center
montefioreeinstein.org
HQ Phone
Get MD Balazs's Phone NumberMobile
Get MD Balazs's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
NY State Medical License
2009 - 2026
OH State Medical License
2004 - 2010
MA State Medical License
2000 - 2004
Beth Israel Deaconess Medical Center
Fellowship • Hematology and Medical Oncology
1998 - 2001
Icahn School of Medicine at Mount Sinai/Morningside/West
Residency • Internal Medicine
1995 - 1998
Semmelweis University
Medical School
Until 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 62 | 183 |
| 2 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 28 | 90 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 22 | 32 |
| 4 | 99221Initial hospital inpatient care, typically 30 minutes per day | 19 | 19 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 14 | 16 |
Authors: Avrum Spira
Journal: Am J Respir Crit Care Med
Immunotherapy for metastatic non-small cell lung cancer: Is it really a no-brainer?
Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells.
Authors: Agarwal, Banke, Halmos, Balazs, Feoktistov, Aleksander S, Protiva, Petr, Ramey, William G, Chen, Ming, Pothoulakis, Charalabos, Lamont, J Thomas, Holt, Peter R
Journal: Carcinogenesis
Lead Sponsor: Columbia University
Intervention / Treatment: OTHER: Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation
Lead Sponsor: Black Diamond Therapeutics, Inc.
Intervention / Treatment: DRUG: silevertinib (BDTX-1535) monotherapy
Lead Sponsor: Montefiore Medical Center
Collaborators: National Cancer Institute (NCI), The Leukemia and Lymphoma Society, Albert Einstein College of Medicine
Intervention / Treatment: BIOLOGICAL: BNT162b2 vaccine